AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glymset-MV2 Tablet SR

Prescription Icon
Prescription Required

Marketer

Razenta pharmaceuticals Pvt Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)

Overview Glymset-MV2 Tablet SR

Diabetic patients, specifically adults with type 2 diabetes mellitus, may benefit from the use of the extended-release combination medication, Glymset-MV2 Tablet SR. This anti-diabetic agent effectively manages blood glucose levels. Consistent daily administration, always taken with food at the same time, maximizes therapeutic impact. Dosage is individually determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use, regardless of perceived well-being or apparent blood sugar control, is crucial. Discontinuation without medical supervision elevates the risk of hyperglycemia, potentially leading to severe complications such as nephropathy, retinopathy, neuropathy, and limb loss. Remember, Glymset-MV2 Tablet SR is one component of a comprehensive diabetes management plan encompassing a balanced diet, regular physical activity, and weight management as directed by your healthcare provider. Lifestyle modifications significantly influence diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by symptoms such as sweating, lightheadedness, cephalalgia, and tremors. Prompt recognition and treatment are essential; carry a fast-acting carbohydrate source, such as glucose tablets or juice, to counteract hypoglycemic episodes. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Additional possible adverse reactions include altered taste perception, nausea, diarrhea, abdominal discomfort, edema, visual disturbances, bone fractures, upper respiratory infections, and weight gain. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or significant hepatic or renal impairment. Individuals with a history of cardiovascular disease should inform their physician before commencing treatment. Pregnant or lactating women should seek medical counsel prior to initiating Glymset-MV2 Tablet SR. Regular blood glucose monitoring is vital, along with potential blood tests to assess hematologic parameters and hepatic function as deemed necessary by your doctor.

Uses of Glymset-MV2 Tablet SR

Managing type 2 diabetes

Major Benefits of Glymset-MV2 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for Glymset-MV2 Tablet SR. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.

Common Side effects of Glymset-MV2 Tablet SR:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Glymset-MV2 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glymset-MV2 Tablet SR whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.

How Glymset-MV2 Tablet SR works:

Glymset-MV2 sustained-release tablets contain a triple combination of antidiabetic agents.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glymset-MV2 Tablet SR and alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glymset-MV2 Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the potential advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The extended-release Glymset-MV2 Tablet likely poses a risk to breastfeeding infants. Available human data indicate potential transfer to breast milk with the possibility of infant harm.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if you experience these conditions.

KidneyKidneyUNSAFE

Employing Glymset-MV2 Tablet SR carries a high risk for individuals with kidney impairment and should be strictly avoided. Medical advice is essential. Furthermore, its use is contraindicated in patients exhibiting severe kidney dysfunction.

LiverLiverCAUTION

Patients with liver impairment should use Glymset-MV2 Tablet SR cautiously, potentially requiring dosage modification. A physician's consultation is recommended. Initial Glymset-MV2 Tablet SR prescriptions for those with mild to moderate hepatic dysfunction should employ a low dosage; the medication is contraindicated in cases of severe liver disease.

What if you forget to take Glymset-MV2 Tablet SR :

Should you forget to take a Glymset-MV2 Tablet SR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glymset-MV2 Tablet SR

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Glymset-MV2 Tablet SR

Glymset-MV2 SR tablets combine glimepiride, metformin, and voglibose to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, metformin reduces liver glucose production and enhances insulin sensitivity, and voglibose, an alpha-glucosidase inhibitor, lowers postprandial glucose. This medication is not suitable for type 1 diabetes.
Glymset-MV2 Tablet SR may cause common side effects including low blood sugar (hypoglycemia), nausea, diarrhea, altered taste perception, gas, stomach pain, headache, skin rash, and respiratory infections.
Glymset-MV2 Tablet SR is contraindicated in patients with allergies to its components or excipients, those with moderate to severe kidney disease, and those with inflammatory bowel disease, colonic ulcerations, or underlying metabolic acidosis, including diabetic ketoacidosis.
Combining Glymset-MV2 Tablet SR and alcohol is unsafe. This combination may cause dangerously low blood sugar and raise the risk of lactic acidosis.
Glymset-MV2 Tablet SR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Store this medication in its original, tightly closed container as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glymset-MV2 Tablet SR
133
MRP 162
17% off